ArticleCirculation2023

The Need for Randomized Trials to Define the Optimal Dose of Anticoagulants for Atrial Fibrillation in Chronic Kidney Disease.

Sean D Pokorney et al.PubMed ↗Publisher ↗

No numbers read from the abstract.